Report: Two-pill abortion regimen 22X more dangerous than what FDA claims

By avagrace // 2025-05-04

Mastodon

Parler

Gab

Copy

A new report reveals that 10 percent of women taking the abortion pill regimen (mifepristone and misoprostol) suffer severe complications – 22 times higher than the FDA's claimed 0.5 percent rate. Risks include infections, hemorrhaging and death.
The FDA has relied on limited, industry-funded studies to justify loosening restrictions, including allowing mail-order distribution without medical supervision, despite real-world data showing significant dangers.
Mifepristone's 2000 approval was contentious, with ties to eugenics-linked groups. Early safety protocols were removed under the Biden administration, despite rising complication rates.
Emergency rooms report increasing cases of incomplete abortions and severe side effects. Many complications go unreported due to out-of-pocket payments or lack of insurance claims.
Pro-life advocates and medical experts demand stricter FDA oversight, including mandatory doctor visits and congressional hearings, arguing the drug would be pulled if not for its abortion ties.

A shocking new report has exposed that the two-pill abortion regimen – marketed as a safe and convenient at-home procedure – is far more dangerous than the Food and Drug Administration (FDA) has publicly admitted. According to research from the Foundation for the Restoration of America (FFROA), one in 10 women who take mifepristone and misoprostol will suffer severe complications, including life-threatening infections, hemorrhaging or even death. The findings, based on real-world insurance claims data, contradict the FDA’s long-standing claims of minimal risk and raise urgent questions about the agency’s oversight of chemical abortions. The abortion pill regimen now accounts for 63 percent of all U.S. abortions. It involves two drugs: Mifepristone (which blocks progesterone to starve an unborn child) and misoprostol (which induces contractions to expel the fetus). While abortion advocates and the FDA have insisted the process is safe, the FFROA study reveals a starkly different reality. (Related: Tennessee lawmakers introduce legislation to deter mail-based abortion pill deliveries.) Analyzing data from hundreds of thousands of women between 2017 and 2023, researchers found that 10.93 percent experienced serious complications. This number was 22 times higher than the FDA's claimed rate of just 0.5 percent. These complications include sepsis, emergency surgeries, blood transfusions and ruptured ectopic pregnancies. Even more alarming, 85 percent of women reported severe side effects such as nausea, fever and hemorrhaging. For years, the FDA has relied on limited clinical trials – many funded by abortion industry groups – to justify loosening restrictions on mifepristone. In 2021, the Biden administration exploited the Wuhan coronavirus (COVID-19) pandemic to eliminate in-person doctor visits, allowing the drug to be mailed directly to women without medical supervision. By 2023, the FDA made this policy permanent, despite mounting evidence of harm. Critics argue the agency has ignored real-world data in favor of political expediency. "These shocking findings should alert all women that the abortion pills are extremely dangerous to their well-being – a conclusion completely at odds with what the FDA tells us," FFROA founder Doug Truax told the Daily Wire. "If you had any other drug that was kind of similar in terms of the magnitude of what this thing does, anywhere north of two percent and they'd shut it down. They're just hell-bent on just increasing the amount of abortions."

How mifepristone's approval put women at risk

Mifepristone's approval in 2000 was mired in controversy. The drug was developed with funding from billionaire Warren Buffett and pushed by the Population Council, an organization with ties to eugenics. Early cases of fatal infections were dismissed by manufacturers, including Danco Laboratories, a secretive firm that refuses to disclose its leadership. Even under the Clinton administration, the FDA imposed strict safety protocols, including mandatory in-person visits. But under former President Joe Biden, those safeguards were stripped away despite rising complication rates. Behind the statistics are real women suffering devastating consequences. Emergency room doctors report an influx of patients with incomplete abortions, severe bleeding and infections. "This is much different than the lie that women have been told that these drugs are safer than Tylenol," said ob-gyn Dr. Christina Francis. The FFROA study also highlights that government insurance data likely undercounts complications, as many women pay out-of-pocket or seek emergency care without filing claims. Pro-life leaders and medical experts are demanding immediate action. Heartbeat International President Jor-El Godsey urged the FDA to reinstate safety protocols, including mandatory doctor visits and stricter reporting requirements. Some lawmakers are calling for congressional hearings to investigate the FDA's handling of mifepristone. The FFROA report is a wake-up call. As chemical abortions surge, women are paying the price for an industry that prioritizes profit over safety and a government that turns a blind eye. The FDA must answer for its negligence before more lives are lost. Watch a 2023 video on the U.S. Supreme Court restoring access to the mifepristone abortion pill. This video is from the Pool Pharmacy channel on Brighteon.com.

CITIZENS NEWS

How mifepristone's approval put women at risk

More related stories: